Althea has acquired Tricycle Day to enhance psychedelic education and access as the industry grows in the United States.

Information on the Target

Althea, a public benefit company focused on establishing infrastructure for regulated psychedelic therapy, has announced its acquisition of Tricycle Day, the foremost independent newsletter dedicated to psychedelic education. This strategic move unites two organizations with a shared mission: assisting individuals in navigating psychedelic care responsibly and effectively.

Tricycle Day, founded by esteemed writer and analyst Henry Winslow, is a trusted source for psychedelic education, reaching tens of thousands of readers weekly. Under this acquisition, Winslow will take on the role of President at Althea, guiding consumer education and demand strategies while maintaining his editorial leadership at Tricycle Day.

Industry Overview in the Target’s Specific Country

The landscape for psychedelic therapy in the United States is evolving rapidly, with increasing legalization and state regulation. Notably, Colorado and Oregon currently operate state-regulated psilocybin progra

View Source

Similar Deals

Gannet BioChem Laysan Bio

2026

Other Proprietary & Advanced Pharmaceuticals United States of America
Merck Revolution Medicines

2026

Other Bio Therapeutic Drugs United States of America
Boston Scientific Corporation Valencia Technologies Corporation

2026

Other Medical Devices & Implants United States of America
Edwards Lifesciences JenaValve Technology

2026

Other Medical Devices & Implants United States of America
Firstsource Solutions Limited TeleMedik

2026

Other Telemedicine Services United States of America
Shelter Real Estate Investment Strategies and Calson Management Atria Park of San Mateo

2026

Other Residential & Long-Term Care United States of America

Althea

invested in

Tricycle Day

in 2026

in a Other deal

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert